Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AERI

Aerie Pharmaceuticals (AERI) Stock Price, News & Analysis

Aerie Pharmaceuticals logo

About Aerie Pharmaceuticals Stock (NASDAQ:AERI)

Advanced Chart

Key Stats

Today's Range
$15.25
$15.25
50-Day Range
$15.18
$15.25
52-Week Range
$4.81
$15.37
Volume
600 shs
Average Volume
974,748 shs
Market Capitalization
$753.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AERI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aerie Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AERI Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
20 Countries With Worst Vision Problems
See More Headlines

AERI Stock Analysis - Frequently Asked Questions

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($0.72) EPS for the quarter, missing the consensus estimate of ($0.62) by $0.10. The business had revenue of $29.31 million for the quarter, compared to analyst estimates of $29.13 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aerie Pharmaceuticals investors own include Canopy Growth (CGC), Nicox (NICXF), Bristol Myers Squibb (BMY), Meta Platforms (META), NVIDIA (NVDA), Pfizer (PFE) and Melinta Therapeutics (MLNT).

Company Calendar

Last Earnings
11/04/2021
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AERI
Employees
376
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.81 million
Pretax Margin
-16.47%

Debt

Sales & Book Value

Annual Sales
$194.13 million
Price / Cash Flow
N/A
Book Value
($3.32) per share
Price / Book
-4.59

Miscellaneous

Free Float
47,223,000
Market Cap
$753.61 million
Optionable
Optionable
Beta
-0.06

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:AERI) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners